Resources

Latest Entry
Press Releases
Media Coverage
Scientific Publications
Case Studies
Blog

Press Release

September 22nd, 2022

CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development 

read more

Press Release

January 23rd, 2023

CytoReason to License Its IBD Disease Model to Sanofi in Expanded Multiyear, Multimillion Dollar Deal

read more
Media Coverage
November 29th, 2022

Poolbeg Pharma reaches R&D milestone as partner CytoReason completes AI influenza disease model

Poolbeg Pharma reaches R&D milestone as partner CytoReason completes AI influenza disease model
read more
Media Coverage
September 22nd, 2022

CytoReason, Pfizer ink $110M, 5-year extension of AI-powered drug development deal

read more
Blog

The Growth Factor

As we expand our partnership with Pfizer in the company’s most significant agreement to date, we find ourselves thinking about the CytoReason “growth factor”—the key agent to our company’s success
read more
Media Coverage
June 24th, 2022

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

read more

Bring your data to life